Search

Your search keyword '"Hirsch, HH."' showing total 63 results

Search Constraints

Start Over You searched for: Author "Hirsch, HH." Remove constraint Author: "Hirsch, HH." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
63 results on '"Hirsch, HH."'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area.

4. BK Polyomavirus (BKPyV) Serotype-Specific Antibody Responses in Blood Donors and Kidney Transplant Recipients with and without new-onset BKPyV-DNAemia: A Swiss Transplant Cohort Study.

5. Transient biopsy-proven progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome (PML-IRIS) in an elderly woman without known immunodeficiency: a case report.

6. Single-cell RNA-sequencing of BK polyomavirus replication in primary human renal proximal tubular epithelial cells identifies specific transcriptome signatures and a novel mitochondrial stress pattern.

7. Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).

8. A Hitchhiker's Guide to the BK Galaxy.

9. Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV.

10. Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy.

11. Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study.

12. Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication-an international CERTAIN registry study.

13. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.

14. Reducing Immunosuppression for BK Polyomavirus-What to do About Corticosteroids?

15. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.

16. Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms.

17. Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.

18. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.

19. Structural implications of BK polyomavirus sequence variations in the major viral capsid protein Vp1 and large T-antigen: a computational study.

20. Impact of Swabbing Location, Self-Swabbing, and Food Intake on SARS-CoV-2 RNA Detection.

21. Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunity.

22. Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?

23. Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.

24. Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?

25. Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia.

26. Impact of bronchoalveolar lavage on the management of immunocompromised hosts.

27. Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series.

28. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.

29. Urine CXCL10 to Assess BK Polyomavirus Replication After Kidney Transplantation.

30. American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.

31. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland.

32. Amplicon size and non-encapsidated DNA fragments define plasma cytomegalovirus DNA loads by automated nucleic acid testing platforms: A marker of viral cytopathology?

33. Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).

34. The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata.

35. A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center.

36. Molecular Characterization of BK Polyomavirus Replication in Allogeneic Hematopoietic Cell Transplantation Patients.

37. Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.

38. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.

39. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.

40. Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach.

41. Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping.

42. Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.

43. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.

44. BK Polyomavirus Consensus.

45. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study.

46. Nitrogen fixation and mucilage production on maize aerial roots is controlled by aerial root development and border cell functions.

47. Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.

48. A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.

49. Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.

50. Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.

Catalog

Books, media, physical & digital resources